355 Results

People

  1. Kris
    Kris
  2. Travis
    Travis
  3. Ladanyi
    Ladanyi
  4. Riely
    Riely
  5. Adusumilli
    Adusumilli
  6. Rusch
    Rusch
  7. Pao
    Pao
  8. Jones
    Jones
  9. Miller
    Miller
  10. Rekhtman
    Rekhtman

Groups

  1. Department of Medicine (140)
  2. Solid Tumor Oncology Division (130)
  3. Thoracic Oncology (116)
  4. Surgery (106)
  5. GSK Faculty (101)
  6. Human Oncology and Pathogenesis Program (81)
  7. Tow Center for Developmental Oncology (TCDO) (78)
  8. Sloan Kettering Institute Postdocs (76)
  9. Epidemiology and Biostatistics (50)
  10. Radiology, Department of (43)
  1. "lung adenocarcinoma"
Formats
  1. Journal Article (327)
  2. Meeting Abstract (10)
  3. Review (7)
  4. Editorial (4)
  5. Research Letter (4)
  6. Correspondence (2)
  7. Conference Paper (1)
Groups
  1. Department of Medicine (140)
  2. Solid Tumor Oncology Division (130)
  3. Thoracic Oncology (116)
  4. Surgery (106)
  5. GSK Faculty (101)
  6. Human Oncology and Pathogenesis Program (81)

More Groups

People
  1. William Travis (78)
  2. Marc Ladanyi (71)
  3. Mark Kris (68)
  4. Gregory Riely (50)
  5. Prasad Adusumilli (47)
  6. Valerie Rusch (46)

More People

Years
  1. 2024 (2)
  2. 2023 (18)
  3. 2022 (13)
  4. 2021 (16)
  5. 2020 (30)
  6. 2019 (12)

More Years

Publications
  1. Journal of Thoracic Oncology (63)
  2. Clinical Cancer Research (19)
  3. Cancer (14)
  4. Modern Pathology (12)
  5. Journal of Thoracic and Cardiovascular Surgery (11)
  6. Lung Cancer (10)

More Publications

Publishers
  1. Elsevier Inc. (88)
  2. American Association for Cancer Research (27)
  3. Wiley Blackwell (26)
  4. Elsevier Science, Inc. (19)
  5. Oxford University Press (14)
  6. Nature Publishing Group (13)

More Publishers

Results (355)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Quantitative MRI evaluation of ferritin overexpression in non-small-cell lung cancer
    Journal Article

    Singhania, M.; Zaher, A.; Pulliam, C. F.; Bayanbold, K.; Searby, C. C.; Schoenfeld, J. D.; Mapuskar, K. A.; Fath, M. A.; Allen, B. G.; Spitz, D. R.; more...
    International Journal of Molecular Sciences (2024)

    Fulltext@MSK | Save
  • Clinical approach and utilizing liquid biopsies to interrogate suspected acquired resistance to PD-1 blockade
    Journal Article

    De Silva, D. L.; Luo, J.
    Future Science OA (2024)

    Fulltext@MSK | Save
  • Spontaneous bilateral chylothorax development during alectinib therapy for ALK-rearranged NSCLC—A case report
    Journal Article

    Bajaj, S.; Chow, A.; Drilon, A.; Kalchiem-Dekel, O.
    JTO Clinical and Research Reports (2023)

    Fulltext@MSK | Save
  • Preoperative (18)F-FDG PET/CT and CT radiomics for identifying aggressive histopathological subtypes in early stage lung adenocarcinoma
    Journal Article

    Choi, W.; Liu, C. J.; Alam, S. R.; Oh, J. H.; Vaghjiani, R.; Humm, J.; Weber, W.; Adusumilli, P. S.; Deasy, J. O.; Lu, W.
    Computational and Structural Biotechnology Journal (2023)

    Fulltext@MSK | Save
  • Inhibition of HSP90 in driver oncogene-defined lung adenocarcinoma cell lines: Key proteins underpinning therapeutic efficacy
    Journal Article

    Marrugal, Á; Ferrer, I.; Quintanal-Villalonga, Á; Ojeda, L.; Pastor, M. D.; García-Luján, R.; Carnero, A.; Paz-Ares, L.; Molina-Pinelo, S.
    International Journal of Molecular Sciences (2023)

    Fulltext@MSK | Save
  • Health utility analysis of tepotinib in patients with non-small cell lung cancer harboring MET exon 14 skipping
    Journal Article

    Yang, M.; Vioix, H.; Hook, E. S.; Hatswell, A. J.; Batteson, R. L.; Gaumond, B. R.; O'Brate, A.; Popat, S.; Paik, P. K.
    Value in Health (2023)

    Fulltext@MSK | Save
  • Combination therapy with MDM2 and MEK inhibitors is effective in patient-derived models of lung adenocarcinoma with concurrent oncogenic drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Markov, V.; Caeser, R.; Sobczuk, P.; Tischfield, S. E.; Bhanot, U.; Vanderbilt, C. M.; Cheng, E. H.; Drilon, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Safety and efficacy results from iSABR, a phase 1 study of stereotactic ablative radiotherapy in combination with durvalumab for early-stage medically inoperable non-small cell lung cancer
    Research Letter

    Wu, T. C.; Stube, A.; Felix, C.; Oseguera, D.; Romero, T.; Goldman, J.; Garon, E. B.; Lee, J. M.; Glaspy, J.; Lisberg, A. E.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Fast, light, and scalable: Harnessing data-mined line annotations for automated tumor segmentation on brain MRI
    Journal Article

    Swinburne, N. C.; Yadav, V.; Murthy, K. N. K.; Elnajjar, P.; Shih, H. H.; Panyam, P. K.; Santilli, A.; Gutman, D. C.; Pike, L.; Moss, N. S.; more...
    European Radiology (2023)

    Fulltext@MSK | Save
  • Efficacy of PD-(L)1 blockade monotherapy compared with PD-(L)1 blockade plus chemotherapy in first-line PD-L1-positive advanced lung adenocarcinomas: A cohort study
    Journal Article

    Elkrief, A.; Alessi, J. M. V.; Ricciuti, B.; Brown, S.; Rizvi, H.; Preeshagul, I. R.; Wang, X.; Pecci, F.; Di Federico, A.; Lamberti, G.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save